Cargando…

COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges

Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Moubarak, Simon, Merheb, Diala, Basbous, Lynn, Chamseddine, Nathalie, Bou Zerdan, Maroun, Assi, Hazem I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515530/
https://www.ncbi.nlm.nih.gov/pubmed/36154328
http://dx.doi.org/10.1177/03000605221125047
_version_ 1784798503501824000
author Moubarak, Simon
Merheb, Diala
Basbous, Lynn
Chamseddine, Nathalie
Bou Zerdan, Maroun
Assi, Hazem I
author_facet Moubarak, Simon
Merheb, Diala
Basbous, Lynn
Chamseddine, Nathalie
Bou Zerdan, Maroun
Assi, Hazem I
author_sort Moubarak, Simon
collection PubMed
description Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical healthcare system to alter its approach to lung cancer. This narrative review aims to identify the effect of the COVID-19 pandemic on lung cancer screening, diagnosis and management. During this public health crisis, various medical societies have worked on developing guidelines to protect patients with lung cancer from the deleterious effects of SARS-CoV-2 infection, as well as from the complications imposed by treatment delays. The different therapeutic approaches, such as surgery, radiation oncology and immune checkpoint inhibitor therapy, along with the latest international recommendations, will be discussed. Protecting patients with lung cancer from COVID-19 complications, while avoiding barriers in treatment delays, has brought unique challenges to healthcare facilities. Prompt modifications to guidelines, and constant evaluation of their efficacy, are thus needed.
format Online
Article
Text
id pubmed-9515530
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-95155302022-09-29 COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges Moubarak, Simon Merheb, Diala Basbous, Lynn Chamseddine, Nathalie Bou Zerdan, Maroun Assi, Hazem I J Int Med Res Review Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical healthcare system to alter its approach to lung cancer. This narrative review aims to identify the effect of the COVID-19 pandemic on lung cancer screening, diagnosis and management. During this public health crisis, various medical societies have worked on developing guidelines to protect patients with lung cancer from the deleterious effects of SARS-CoV-2 infection, as well as from the complications imposed by treatment delays. The different therapeutic approaches, such as surgery, radiation oncology and immune checkpoint inhibitor therapy, along with the latest international recommendations, will be discussed. Protecting patients with lung cancer from COVID-19 complications, while avoiding barriers in treatment delays, has brought unique challenges to healthcare facilities. Prompt modifications to guidelines, and constant evaluation of their efficacy, are thus needed. SAGE Publications 2022-09-25 /pmc/articles/PMC9515530/ /pubmed/36154328 http://dx.doi.org/10.1177/03000605221125047 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Moubarak, Simon
Merheb, Diala
Basbous, Lynn
Chamseddine, Nathalie
Bou Zerdan, Maroun
Assi, Hazem I
COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
title COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
title_full COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
title_fullStr COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
title_full_unstemmed COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
title_short COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
title_sort covid-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515530/
https://www.ncbi.nlm.nih.gov/pubmed/36154328
http://dx.doi.org/10.1177/03000605221125047
work_keys_str_mv AT moubaraksimon covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges
AT merhebdiala covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges
AT basbouslynn covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges
AT chamseddinenathalie covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges
AT bouzerdanmaroun covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges
AT assihazemi covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges